GlaxoSmithKline in China: Challenges Faced
China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.
Updated 14 hours ago
Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round
Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.
Updated 11 seconds ago
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Aug 12, 2022 03:00 PM